Evidence map›Paper›PMID 30430094›Full record

ArticleSouth Asian journal of cancer

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients.

Vijay Patil, Amit Joshi, Vanita Noronha, Atanu Bhattacharjee, Sachin Dhumal, M V Chandrakanth, Ashay Karpe, Vikas Talreja, Arun Chandrasekharan, Siddharth Turkar and 3 more

Open access · diamondAbstract read
In one paragraph

Article in South Asian journal of cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Vijay PatilDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Amit JoshiDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Atanu BhattacharjeeDepartment of Statistics and Epidemiology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Sachin DhumalDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
M V ChandrakanthDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Ashay KarpeDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Vikas TalrejaDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Arun ChandrasekharanDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Siddharth TurkarDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Nikhil PandeDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Anant RamaswamyDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Tata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuality-adjusted time without toxicity (Q-TWiST) and quality of life (QOL) are indicators of benefit provided by different chemotherapy regimens.

methodsThis was a prospective study, in which adult head-and-neck (H and N) cancer patients, treated with metronomic chemotherapy were enrolled. The Functional Assessment of Cancer Therapy-General H and N (FACT-G and H and N) version 4 pro formas were self-administered before the start of chemotherapy and then at 2, 4, and 6 months. FACT QOL and Q-TWiST analysis were then performed.

resultsThere was an improvement in the social well-being (

conclusionMetronomic chemotherapy is associated with improvement in QOL and has a low duration of time spent in toxicity state.

Indexed as

FACTheadneck cancerspalliative chemotherapyquality-adjusted time without toxicityquality of life

Identifiers

PMID30430094
PMCPMC6190391
OpenAlexW2895683271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.